drugset / Trial / NCT06773351
A Response Surface Analysis for the Interaction Between Ciprofol and Sevoflurane
RandomizedParallel-groupTriple-blindTreatment
Summary
Intravenous and inhalation combined anesthesia is a commonly used method for maintaining general anesthesia in clinical practice. This study aims to explore the interaction between ciprofol and sevoflurane. By employing response surface methodology, we constructed a three-dimensional pharmacodynamic interaction surface for various dose combinations of ciprofol and sevoflurane. This approach allows us to determine the nature of the interaction between the two drugs at any given level, thereby providing a ciprofol understanding of the dose-response relationship when ciprofol and sevoflurane are used in combination. This knowledge will serve as a theoretical basis for rational drug administration during surgery.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipepofol | Small molecule | 0.05 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.1 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.15 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.2 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.3 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.4 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.5 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.6 mg/kg | — |
| Subject | Sevoflurane | Other / unclassified | 0.5 % | — |
| Subject | Sevoflurane | Other / unclassified | 0.7 % | — |
| Subject | Sevoflurane | Other / unclassified | 1 % | — |
| Subject | Sevoflurane | Other / unclassified | 1.5 % | — |
| Subject | Sevoflurane | Other / unclassified | 2 % | — |
| Subject | Sevoflurane | Other / unclassified | 2.5 % | — |
| Subject | Sevoflurane | Other / unclassified | 3 % | — |
| Subject | Sevoflurane | Other / unclassified | 3.5 % | — |
Indications
No indication recorded.